Designing a long acting erythropoietin by fusing three carboxyl-terminal peptides of human chorionic gonadotropin subunit to the N -terminal and C -terminal coding sequence

International Journal of Cell Biology

Volumn , Issue , 2011, Pages

  Fares, Fuad ^a   Havron, Avri ^b,c   Fima, Eyal ^b,c  

^a UNIVERSITY OF HAIFA   (Israel)

^b Weizmann Science Park   (Israel)

^c Weizmann Science Park   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ERYTHROPOIETIN; ERYTHROPOIETIN (CARBOXYTERMINAL PEPTIDE) 3; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CHO CELL; CONTROLLED STUDY; DRUG DESIGN; DRUG HALF LIFE; HEMATOCRIT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE;

ANIMALIA; MUS;

EID: 80053481188     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2011/275063     Document Type: Article

References (36)

1. Jelkmann W., Erythropoietin: structure, control of production, and function Physiological Reviews 1992 72 2 449 487
2. Schuster S., Wilson J. H., Erslev A. J., Caro J., Physiologic regulation and tissue localization of renal erythropoietin messenger RNA Blood 1987 70 1 316 318 (Pubitemid 17111280)
3. Parry D. A., Minasian E., Leach S. J., Conformational homologies among cytokines: interleukins and colony stimulating factors Journal of Molecular Recognition 1988 1 3 107 110
4. Watowich S. S., Yoshimura A., Longmore G. D., Hilton D. J., Yoshimura Y., Lodish H. F., Homodimerization and constitutive activation of the erythropoietin receptor Proceedings of the National Academy of Sciences of the United States of America 1992 89 6 2140 2144
5. Youssoufian H., Longmore G., Neumann D., Yoshimura A., Lodish H. F., Structure, function, and activation of the erythropoietin receptor Blood 1993 81 9 2223 2236 (Pubitemid 23127056)
6. Ihle J. N., Cytokine receptor signalling Nature 1995 377 6550 591 594
7. Remy I., Wilson I. A., Michnick S. W., Erythropoietin receptor activation by a ligand-induced conformation change Science 1999 283 5404 990 993
8. Wasley L. C., Timony G., Murtha P., Stoudemire J., Dorner A. J., Caro J., Krieger M., Kaufman R. J., The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin Blood 1991 77 12 2624 2632
9. Jacobs K., Shoemaker C., Rudersdorf R., Isolation and characterization of genomic and cDNA clones of human erythropoietin Nature 1985 313 6005 806 810 (Pubitemid 15130833)
10. Lin F. K., Suggs S., Lin C. H., Cloning and expression of the human erythropoietin gene Proceedings of the National Academy of Sciences of the United States of America 1985 82 7580 7584 (Pubitemid 16204391)
11. Platanias L. C., Miller C. B., Mick R., Hart R. D., Ozer H., McEvilly J. M., Jones R. J., Ratain M. J., Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients Journal of Clinical Oncology 1991 9 11 2021 2026
12. Henry D. H., Experience with epoetin alfa and acquired immunodeficiency syndrome anemia Seminars in Oncology 1998 25 3 64 67
13. Ludwig H., Sundal E., Pecherstorfer M., Leitgeb C., Bauernhofer T., Beinhauer A., Samonigg H., Kappeler A. W., Fritz E., Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy Cancer 1995 76 11 2319 2329
14. Macdougall I. C., Optimizing the use of erythropoietic agentspharmacokinetic and pharmacodynamic considerations Nephrology Dialysis Transplantation 2002 17 supplement 5 66 70
15. Matzuk M. M., Hsueh A. J. W., Lapolt P., Tsafriri A., Keene J. L., Boime I., The biological role of the carboxyl-terminal extension of human chorionic gonadotropin -subunit Endocrinology 1990 126 4 376 383 (Pubitemid 20037166)
16. van den Hamer C. J., Morell A. G., Scheinberg I. H., Hickman J., Ashwell G., Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation Journal of Biological Chemistry 1970 245 17 4397 4402
17. Pierce J., Parsons T. F., Glycoprotein hormones: structure and function Annual Review of Biochemistry 1981 50 465 495 (Pubitemid 12164355)
18. Fares F. A., Suganuma N., Nishimori K., LaPolt P. S., Hsueh A. J. W., Boime I., Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin subunit Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4304 4308
19. Lapolt P. S., Nishimori K., Fares F. A., Perlas E., Boime I., Hsueh A. J. W., Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl- terminal peptides Endocrinology 1992 131 6 2514 2520
20. Joshi L., Murata Y., Wondisford F. E., Szkudlinski M. W., Desai R., Weintraub B. D., Recombinant thyrotropin containing a -subunit chimera with the human chorionic gonadotropin- carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance Endocrinology 1994 136 3839 3848
21. Fares F., Ganem S., Hajouj T., Agai E., Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin -subunit to the coding sequence of human erythropoietin Endocrinology 2007 148 10 5081 5087 (Pubitemid 47481521)
22. Fares F., Guy R., Bar-Ilan A., Felikman Y., Fima E., Designing a long-acting human growth hormone (hGH) by fusing the carboxyl-terminal peptide of human chorionic gonadotropin -subunit to the coding sequence of hGH Endocrinology 2010 151 9 4410 4417
23. Raves M. L., Harel M., Pang Y. P., Silman I., Kozikowski A. P., Sussman J. L., Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A Nature Structural Biology 1997 4 1 57 63 (Pubitemid 27020926)
24. Laemmli U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 1970 227 5259 680 685
25. Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y. F., Miyazono K., Urabe A., Takaku F., Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin Journal of Cellular Physiology 1989 140 2 323 334 (Pubitemid 19185998)
26. Jentoft N., Why are proteins O-glycosylated? Trends in Biochemical Sciences 1990 14 8 272 275
27. Wide L., The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone Acta Endocrinologica 1986 112 3 336 344 (Pubitemid 16061983)
28. Egrie J. C., Browne J. K., Development and characterization of novel erythropoiesis stimulating protein (NESP) British Journal of Cancer 2001 84 supplement 1 3 10 (Pubitemid 32453429)
29. Bouloux P. M., Handelsman D. J., Jockenhvel F., Nieschlag E., Rabinovici J., Frasa W. L.H., De Bie J. J., Voortman G., Itskovitz-Eldor J., First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males Human Reproduction 2001 16 8 1592 1597 (Pubitemid 32761736)
30. Duijkers I. J., Klipping C., Boerrigter P. J., Machielsen C. S. M., de Bie J. J., Voortman G., Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Human Reproduction 2002 17 8 1987 1993
31. Devroey P., Fauser B. C., Platteau P., Beckers N. G., Dhont M., Mannaerts B. M., Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization Journal of Clinical Endocrinology and Metabolism 2004 89 5 2062 2070 (Pubitemid 38647174)
32. Eschbach J. W., Egrie J. C., Downing M. R., Browne J. K., Adamson J. W., Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined Phase I and II clinical trial New England Journal of Medicine 1987 316 2 73 78 (Pubitemid 17052741)
33. Evans R. W., Rader B., Manninen D. L., The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group JAMA 1990 263 6 825 830 (Pubitemid 20050894)
34. Winearls C. G., Oliver D. O., Pippard M. J., Reid C., Downing M. R., Coles P. M., Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis Lancet 1986 2 8517 1175 1178
35. Platanias L. C., Miller C. B., Mick R., Hart R. D., Ozer H., McEvilly J. M., Jones R. J., Ratain M. J., Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients Journal of Clinical Oncology 1991 9 11 2021 2026
36. Ludwig H., Sundal E., Pecherstorfer M., Leitgeb C., Bauernhofer T., Beinhauer A., Samonigg H., Kappeler A. W., Fritz E., Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy Cancer 1995 76 11 2319 2329